Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3042]

Pembrolizumab is safe and effective and substantially increases overall...

Dr Edward B. Garon - UCLA, Los Angeles, USA

Pembrolizumab is safe and effective and substantially increases overall survival in aNSCLC patients ( Dr Edward B. Garon - UCLA, Los Angeles, USA )

Latest in ovarian cancer treatment

Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK

Latest in ovarian cancer treatment ( Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK )

Bladder Problems following ovarian cancer treatment

Ellie Stewart - Guy’s and St Thomas NHS Foundation Trust, London, UK

Bladder Problems following ovarian cancer treatment ( Ellie Stewart - Guy’s and St Thomas NHS Foundation Trust, London, UK )

Highlights from ICALL 2019

Prof Hervé Dombret - University Paris Diderot, Paris, France

Highlights from ICALL 2019 ( Prof Hervé Dombret - University Paris Diderot, Paris, France )

Prof Anders Bjartell discusses the data sources and access of the PIONEER data...

Prof Anders Bjartell - Skåne University Hospital, Malmö, Lund University, Sweden

Prof Anders Bjartell discusses the data sources and access of the PIONEER data models ( Prof Anders Bjartell - Skåne University Hospital, Malmö, Lund University, Sweden )

Dr Billy Franks explains the importance of data analysis plans for PIONEER’s...

Dr Billy Franks - Astellas Pharma B.V.

Dr Billy Franks explains the importance of data analysis plans for PIONEER’s research questions ( Dr Billy Franks - Astellas Pharma B.V. )

Denis Horgan explains the importance of actively engaging policy makers in...

Denis Horgan - Executive Director, European Alliance for Personalised Medicine

Denis Horgan explains the importance of actively engaging policy makers in PIONEER ( Denis Horgan - Executive Director, European Alliance for Personalised Medicine )

Prof James N’Dow, Academic lead for PIONEER, reflects on the first twelve...

Prof James N’Dow - Chairperson, European Association of Urology Guidelines...

Prof James N’Dow, Academic lead for PIONEER, reflects on the first twelve months of the project ( Prof James N’Dow - Chairperson, European Association of Urology Guidelines Office )

Louise Fullwood explains the legal and ethical issues around data privacy...

Louise Fullwood - Legal Director, Pinsent Masons

Louise Fullwood explains the legal and ethical issues around data privacy within PIONEER ( Louise Fullwood - Legal Director, Pinsent Masons )

Prof Maria Ribal discusses how effective dissemination is key to PIONEER’s long...

Prof Maria Ribal - Chairperson, EAU Guidelines Dissemination Committee

Prof Maria Ribal discusses how effective dissemination is key to PIONEER’s long-term success ( Prof Maria Ribal - Chairperson, EAU Guidelines Dissemination Committee )

Dr Mieke Van Hemelrijck explains the importance of define core outcome sets for...

Dr Mieke Van Hemelrijck - Kings College London, Translational Oncology &...

Dr Mieke Van Hemelrijck explains the importance of define core outcome sets for prostate cancer ( Dr Mieke Van Hemelrijck - Kings College London, Translational Oncology & Urology Research (TOUR) )

PIONEER research associates from both academic and industry discuss their...

Claudio Sartini, Katharina Beyer, Eleni Vradi, Dr Lisa Morris, Dr Kostas...

PIONEER research associates from both academic and industry discuss their experience of working together ( Claudio Sartini, Katharina Beyer, Eleni Vradi, Dr Lisa Morris, Dr Kostas Dimitropoulos, Dr Peter-Paul Willemse )

More from ecancer